Karin V Rhodes1, Simon Basseyn2,3,4, Robert Gallop2,5, Elizabeth Noll6, Aileen Rothbard2,4,6, Paul Crits-Christoph2. 1. Office of Population Health Management, Hofstra Northwell Medical School, Emergency Medicine Service Line & Northwell Health Solutions, 200 Community Drive, Great Neck, NY, 11021, USA. krhodes@northwell.edu. 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 3. The Wharton School of Business, University of Pennsylvania, Philadelphia, PA, USA. 4. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. 5. West Chester University, West Chester, PA, USA. 6. University of Pennsylvania School of Social Policy and Practice, Philadelphia, PA, USA.
Abstract
BACKGROUND: The Chronic Care Initiative (CCI) was a large state-wide patient-centered medical home (PCMH) initiative in Pennsylvania in place from 2008-2011. OBJECTIVE: Determine whether the CCI impacted the utilization and costs for Medicaid patients with chronic medical conditions and comorbid psychiatric or substance use disorders. DESIGN: Analysis of Medicaid claims using difference-in-difference regression analyses to compare changes in utilization and costs for patients treated at CCI practices to propensity score-matched patients treated at comparison non-CCI practices. SETTING: Ninety-six CCI practices in Pennsylvania and 60 non-CCI practices during the same time period. PARTICIPANTS: A total of 11,105 comorbid Medicaid patients treated in CCI practices and an equal number of propensity-matched comparison patients treated in non-CCI practices. MEASUREMENTS: Changes in total per-patient costs from 1 year prior to 1 year following an index episode period. Secondary outcomes included utilization and costs for emergency department (ED), inpatient, and outpatient services. RESULTS: The CCI group experienced an average adjusted total cost savings of $4145.28 per patient per year (P = 0.023) for the CCI relative to the non-CCI group. This was largely driven by a $3521.15 savings (P = 0.046) in inpatient medical costs, in addition to relative savings in outpatient psychiatric ($21.54, P < 0.001) and substance abuse service costs ($16.42, P = 0.013), compared to the non-CCI group. The CCI group, related to the non-CCI group, had decreases in expected mean counts of ED visits (for those who had any) and psychiatric hospitalizations of 15.6 (95 % CI: -21, -9) and 40.7 (95 % CI: -57, -18) percentage points respectively. LIMITATIONS: We do not measure quality of care and cannot make conclusions about the overall cost-effectiveness or long-term effects of the CCI. CONCLUSIONS: The CCI was associated with substantial cost savings, attributable primarily to reduced inpatient costs, among a high-risk group of Medicaid patients, who may disproportionally benefit from care management in patient-centered medical homes.
BACKGROUND: The Chronic Care Initiative (CCI) was a large state-wide patient-centered medical home (PCMH) initiative in Pennsylvania in place from 2008-2011. OBJECTIVE: Determine whether the CCI impacted the utilization and costs for Medicaid patients with chronic medical conditions and comorbid psychiatric or substance use disorders. DESIGN: Analysis of Medicaid claims using difference-in-difference regression analyses to compare changes in utilization and costs for patients treated at CCI practices to propensity score-matched patients treated at comparison non-CCI practices. SETTING: Ninety-six CCI practices in Pennsylvania and 60 non-CCI practices during the same time period. PARTICIPANTS: A total of 11,105 comorbid Medicaid patients treated in CCI practices and an equal number of propensity-matched comparison patients treated in non-CCI practices. MEASUREMENTS: Changes in total per-patient costs from 1 year prior to 1 year following an index episode period. Secondary outcomes included utilization and costs for emergency department (ED), inpatient, and outpatient services. RESULTS: The CCI group experienced an average adjusted total cost savings of $4145.28 per patient per year (P = 0.023) for the CCI relative to the non-CCI group. This was largely driven by a $3521.15 savings (P = 0.046) in inpatient medical costs, in addition to relative savings in outpatientpsychiatric ($21.54, P < 0.001) and substance abuse service costs ($16.42, P = 0.013), compared to the non-CCI group. The CCI group, related to the non-CCI group, had decreases in expected mean counts of ED visits (for those who had any) and psychiatric hospitalizations of 15.6 (95 % CI: -21, -9) and 40.7 (95 % CI: -57, -18) percentage points respectively. LIMITATIONS: We do not measure quality of care and cannot make conclusions about the overall cost-effectiveness or long-term effects of the CCI. CONCLUSIONS: The CCI was associated with substantial cost savings, attributable primarily to reduced inpatient costs, among a high-risk group of Medicaid patients, who may disproportionally benefit from care management in patient-centered medical homes.
Entities:
Keywords:
Behavioral Health Integration; Health Care Reform; Medicaid Utilization and Costs; Patient-Centered Medical Homes; Pennsylvania Chronic Care Initiative; Physical and Mental Health Co-morbidities
Authors: Beat D Steiner; Amy C Denham; Evan Ashkin; Warren P Newton; Thomas Wroth; L Allen Dobson Journal: Ann Fam Med Date: 2008 Jul-Aug Impact factor: 5.166
Authors: Mark W Friedberg; Meredith B Rosenthal; Rachel M Werner; Kevin G Volpp; Eric C Schneider Journal: JAMA Intern Med Date: 2015-08 Impact factor: 21.873
Authors: Ricardo A Mosquera; Elenir B C Avritscher; Cheryl L Samuels; Tomika S Harris; Claudia Pedroza; Patricia Evans; Fernando Navarro; Susan H Wootton; Susan Pacheco; Guy Clifton; Shade Moody; Luisa Franzini; John Zupancic; Jon E Tyson Journal: JAMA Date: 2014 Dec 24-31 Impact factor: 56.272
Authors: Carrie H Colla; David E Wennberg; Ellen Meara; Jonathan S Skinner; Daniel Gottlieb; Valerie A Lewis; Christopher M Snyder; Elliott S Fisher Journal: JAMA Date: 2012-09-12 Impact factor: 56.272
Authors: Paul Crits-Christoph; Robert Gallop; Elizabeth Noll; Aileen Rothbard; Caroline K Diehl; Mary Beth Connolly Gibbons; Robert Gross; Karin V Rhodes Journal: Am J Manag Care Date: 2018-08 Impact factor: 2.229
Authors: Laura-Louise Arundell; Helen Greenwood; Helen Baldwin; Eleanor Kotas; Shubulade Smith; Kasia Trojanowska; Chris Cooper Journal: Syst Rev Date: 2020-05-26
Authors: Sonja MacDonald; Courtney Heisler; Holly Mathias; Raza Mirza; Mark MacMillan; Mark Borgaonkar; Noelle Rohatinsky; Jennifer L Jones Journal: J Can Assoc Gastroenterol Date: 2022-02-04
Authors: Richard A Hansen; Natalie Hohmann; Matthew L Maciejewski; Marisa E Domino; Neepa Ray; Nirosha Mahendraratnam; Joel F Farley Journal: J Pharm Health Serv Res Date: 2017-11-20